1. Dupixent is intended to treat patients with moderate to severe eczema.
2. Zejula can now be used as a maintenance treatment for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
3. Bavencio is the first treatment for metastatic Merkel cell carcinoma, a rare form of skin cancer.
4. Ocrevus is intended to treat patients with severe forms of multiple sclerosis.
More articles on supply chain:
7 must-reads for supply chain leaders this week
America’s focus on technology — rather than medicine — is ‘eroding our national intellect,’ says pharma exec
Bill Ackman calls $4B Valeant investment ‘huge mistake’
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
